<?xml version="1.0" encoding="UTF-8"?>
<p>The results of herb–drug interaction studies of various adaptogens are contradictory.
 <xref rid="med21743-bib-0001" ref-type="ref">
  <sup>1</sup>
 </xref>, 
 <xref rid="med21743-bib-0002" ref-type="ref">
  <sup>2</sup>
 </xref>, 
 <xref rid="med21743-bib-0003" ref-type="ref">
  <sup>3</sup>
 </xref>, 
 <xref rid="med21743-bib-0004" ref-type="ref">
  <sup>4</sup>
 </xref>, 
 <xref rid="med21743-bib-0598" ref-type="ref">
  <sup>598</sup>
 </xref>, 
 <xref rid="med21743-bib-0626" ref-type="ref">
  <sup>626</sup>
 </xref>, 
 <xref rid="med21743-bib-0627" ref-type="ref">
  <sup>627</sup>
 </xref>, 
 <xref rid="med21743-bib-0628" ref-type="ref">
  <sup>628</sup>
 </xref> Interactions with some CYP isoenzymes have been observed in vitro studies only in high concentrations of herbal extracts that are far beyond their blood levels when taken in the standard therapeutic doses and not associated with active markers.
 <xref rid="med21743-bib-0001" ref-type="ref">
  <sup>1</sup>
 </xref>, 
 <xref rid="med21743-bib-0598" ref-type="ref">
  <sup>598</sup>
 </xref>, 
 <xref rid="med21743-bib-0626" ref-type="ref">
  <sup>626</sup>
 </xref>, 
 <xref rid="med21743-bib-0627" ref-type="ref">
  <sup>627</sup>
 </xref>, 
 <xref rid="med21743-bib-0628" ref-type="ref">
  <sup>628</sup>
 </xref> Few poorly conducted clinical studies in limited number of healthy subjects (lack of placebo, proper randomization, procedure for treatment compliance, pharmacokinetic data, sufficiently controlled consumption of CYP‐active food ingredients, etc.) do not provide strong, evidence supporting the clinical relevance of the interaction effects observed in vitro.
</p>
